 | • レポートコード：MRC2304A180 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、245ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に6,483.96百万ドルであった世界の医薬品用膜ろ過市場規模が2022年に7,328.73百万ドルへと拡大、更に2027年までにCAGR 13.20％で成長して13,647.34百万ドルに達すると予測しています。当書は、医薬品用膜ろ過の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（付属品、フィルター、システム）、材料別分析（混合セルロースエステル＆セルロースアセテート、ナイロンメンブレンフィルター、ポリカーボネートトラックエッチング、ポリエーテルスルホン、ポリテトラフルオロエチレン）、技術別分析（イオン交換、精密ろ過、ナノろ過、逆浸透、限外ろ過）、用途別分析（空気浄化、細胞分離、最終製品処理、原料ろ過、水浄化）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの構成でまとめています。なお、当書には、3M Company、Alfa Laval AB、Amazon Filters, Ltd.、ARL Bio Pharma, Inc.、Berghof Membrane Technology GmbH、Danaher Corporation、Donaldson Company, Inc.、Eaton Corporation、GE Healthcare Inc.、GEA Group AGなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の医薬品用膜ろ過市場規模：製品別 - 付属品の市場規模 - フィルターの市場規模 - システムの市場規模 ・世界の医薬品用膜ろ過市場規模：材料別 - 混合セルロースエステル＆セルロースアセテートの市場規模 - ナイロンメンブレンフィルターの市場規模 - ポリカーボネートトラックエッチングの市場規模 - ポリエーテルスルホンの市場規模 - ポリテトラフルオロエチレンの市場規模 ・世界の医薬品用膜ろ過市場規模：技術別 - イオン交換の市場規模 - 精密ろ過の市場規模 - ナノろ過の市場規模 - 逆浸透の市場規模 - 限外ろ過の市場規模 ・世界の医薬品用膜ろ過市場規模：用途別 - 空気浄化における市場規模 - 細胞分離における市場規模 - 最終製品処理における市場規模 - 原料ろ過における市場規模 - 水浄化における市場規模 ・世界の医薬品用膜ろ過市場規模：地域別 - 南北アメリカの医薬品用膜ろ過市場規模 アメリカの医薬品用膜ろ過市場規模 カナダの医薬品用膜ろ過市場規模 ブラジルの医薬品用膜ろ過市場規模 ... - アジア太平洋の医薬品用膜ろ過市場規模 日本の医薬品用膜ろ過市場規模 中国の医薬品用膜ろ過市場規模 インドの医薬品用膜ろ過市場規模 韓国の医薬品用膜ろ過市場規模 台湾の医薬品用膜ろ過市場規模 ... - ヨーロッパ/中東/アフリカの医薬品用膜ろ過市場規模 イギリスの医薬品用膜ろ過市場規模 ドイツの医薬品用膜ろ過市場規模 フランスの医薬品用膜ろ過市場規模 ロシアの医薬品用膜ろ過市場規模 ... - その他地域の医薬品用膜ろ過市場規模 ・競争状況 ・企業情報 |
The Global Pharmaceutical Membrane Filtration Market size was estimated at USD 6,483.96 million in 2021 and expected to reach USD 7,328.73 million in 2022, and is projected to grow at a CAGR 13.20% to reach USD 13,647.34 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Membrane Filtration to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Accessories, Filters, and Systems.
Based on Material, the market was studied across Mixed Cellulose Ester & Cellulose Acetate, Nylon Membrane Filters, Polycarbonate Track-etched, Polyethersulfone, Polytetrafluoroethylene, and Polyvinylidene Difluoride.
Based on Technique, the market was studied across Ion Exchange, Microfiltration, Nanofiltration, Reverse Osmosis, and Ultrafiltration.
Based on Application, the market was studied across Air Purification, Cell Separation, Final Product Processing, Raw Material Filtration, and Water Purification. The Final Product Processing is further studied across Active Pharmaceutical Ingredient Filtration, Formulation & Filling Solutions, Protein Purification, Sterile Filtration, Vaccines & Antibody Processing, and Viral Clearance. The Raw Material Filtration is further studied across Bioburden Reduction, Media Buffers, and Prefiltration.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Membrane Filtration market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Membrane Filtration Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Membrane Filtration Market, including 3M Company, Alfa Laval AB, Amazon Filters, Ltd., ARL Bio Pharma, Inc., Berghof Membrane Technology GmbH, Danaher Corporation, Donaldson Company, Inc., Eaton Corporation, GE Healthcare Inc., GEA Group AG, Graver Technologies, LLC, Koch Membrane Systems, Inc., Koch Separation Solutions, MEISSNER FILTRATION PRODUCTS, INC., Merck KGaA, MMS Membrane Systems, Novasep, LLC, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Simsii Inc., Sterlitech Corporation, Synder Filtration, Inc., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Membrane Filtration Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Membrane Filtration Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Membrane Filtration Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Membrane Filtration Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Membrane Filtration Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Membrane Filtration Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Membrane Filtration Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of single-use technologies
5.1.1.2. Developments in drug production coupled with a wide range of uses of membrane filtration techniques
5.1.2. Restraints
5.1.2.1. High cost associated with the technology
5.1.3. Opportunities
5.1.3.1. Advancements in nanofiltration technology
5.1.4. Challenges
5.1.4.1. Complicated procedures and maintenance issues
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Membrane Filtration Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Filters
6.4. Systems
7. Pharmaceutical Membrane Filtration Market, by Material
7.1. Introduction
7.2. Mixed Cellulose Ester & Cellulose Acetate
7.3. Nylon Membrane Filters
7.4. Polycarbonate Track-etched
7.5. Polyethersulfone
7.6. Polytetrafluoroethylene
7.7. Polyvinylidene Difluoride
8. Pharmaceutical Membrane Filtration Market, by Technique
8.1. Introduction
8.2. Ion Exchange
8.3. Microfiltration
8.4. Nanofiltration
8.5. Reverse Osmosis
8.6. Ultrafiltration
9. Pharmaceutical Membrane Filtration Market, by Application
9.1. Introduction
9.2. Air Purification
9.3. Cell Separation
9.4. Final Product Processing
9.5.1. Active Pharmaceutical Ingredient Filtration
9.5.2. Formulation & Filling Solutions
9.5.3. Protein Purification
9.5.4. Sterile Filtration
9.5.5. Vaccines & Antibody Processing
9.5.6. Viral Clearance
9.5. Raw Material Filtration
9.6.1. Bioburden Reduction
9.6.2. Media Buffers
9.6.3. Prefiltration
9.6. Water Purification
10. Americas Pharmaceutical Membrane Filtration Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Membrane Filtration Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmaceutical Membrane Filtration Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 3M Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Alfa Laval AB
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Amazon Filters, Ltd.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. ARL Bio Pharma, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Berghof Membrane Technology GmbH
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Danaher Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Donaldson Company, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Eaton Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. GE Healthcare Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. GEA Group AG
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Graver Technologies, LLC
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Koch Membrane Systems, Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Koch Separation Solutions
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. MEISSNER FILTRATION PRODUCTS, INC.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Merck KGaA
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. MMS Membrane Systems
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Novasep, LLC
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Parker Hannifin Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Repligen Corporation
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Sartorius Stedim Biotech
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Simsii Inc.
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Sterlitech Corporation
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Synder Filtration, Inc.
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. Thermo Fisher Scientific, Inc.
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing